Bill for It All

Article

Too many physicians forget to billfor supplies and imaging services.

Too many physicians forget to bill for supplies and imaging services. To double-check yourself, match invoices from your medical supply and imaging vendor to supplies and imaging services you billed for.

-Courtesy of
    Physicians Practice

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Cost of Semaglutide, Tirzepatide Prohibitive Despite Significant Benefits

Cost of Semaglutide, Tirzepatide Prohibitive Despite Significant Benefits

Grace Halsey
March 14th 2025
Article

A new economic evaluation estimates that semaglutide would need to drop its current price by 81.9% and tirzepatide by 30.5% to be cost effective.

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

Linda Stein Gold, MD;Sydney Jennings
March 9th 2025
Podcast

“I think it’s important to have a lot of tools in our toolbox, and [tapinarof cream 1%] is one that gives us great flexibility," said Linda Stein Gold, MD.

Bionic Pancreas for Type 1 Diabetes Found Feasible to Implement in Primary Care

Bionic Pancreas for Type 1 Diabetes Found Feasible to Implement in Primary Care

Sydney Jennings
March 14th 2025
Article

The iLet bionic pancreas system conferred an average glucose of less than 183 mg/dL in 97% of adults with T1D in a small study.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Dupilumab Cuts Food Allergy IgE Levels in Small Study: Daily Dose / image credit: ©New Africa/AdobeStock

Dupilumab Cuts Food Allergy IgE Levels in Small Study: Daily Dose

Sydney Jennings
March 14th 2025
Article

Your daily dose of the clinical news you may have missed.

FDA Submission Planned for Nonopioid Cebranopadol Following Positive Phase 3 Results: Tris Pharma Update

FDA Submission Planned for Nonopioid Cebranopadol Following Positive Phase 3 Results: Tris Pharma Update

Grace Halsey
March 13th 2025
Article

Positive findings for postsurgical acute pain relief from the pivotal phase 3 ALLEVIATE-2 trial complete the development program, allowing plans for NDA submission.

© 2025 MJH Life Sciences

All rights reserved.